[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jeanne Tie<\/i><\/u><\/presenter>. Peter MacCallum Cancer Centre, Melbourne, Australia","CSlideId":"","ControlKey":"3c4e6878-ad20-41d2-84a4-a32047126635","ControlNumber":"340","DisclosureBlock":"&nbsp;<b>&nbsp;J. Tie:<\/b>  ; Advisory board; Inivata. ; Inivata. ; AstraZeneca. ; Advisory board; AstraZeneca. ; Advisory board; Bristol Myers Squibb. ; Bristol Myers Squibb. ; Merck Sharp & Dohme. ; advisory board; Merck Sharp & Dohme. ; advisory board; Pierre Fabre. ; Pierre Fabre. ; Novartis. ; advisory board; Novartis.","End":"4\/9\/2022 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"195","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jeanne Tie, MBChB;MD","PresenterKey":"70d27442-7f2c-40be-8a2f-891b872334d4","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"151","SessionOnDemand":"False","SessionTitle":"Minimal Residual Disease in Solid Tumors: What Does It Mean and How Should It Guide Treatment Decision-Making?","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jeanne Tie<\/i><\/u><\/presenter>. Peter MacCallum Cancer Centre, Melbourne, Australia","CSlideId":"","ControlKey":"d63d3908-1990-40c5-9da5-5dbfa913d202","ControlNumber":"4629","DisclosureBlock":"","End":"4\/9\/2022 10:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"373","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jeanne Tie, MBChB;MD","PresenterKey":"70d27442-7f2c-40be-8a2f-891b872334d4","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Potential and challenges of MRD detection with circulating tumor DNA analysis","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"151","SessionOnDemand":"False","SessionTitle":"Minimal Residual Disease in Solid Tumors: What Does It Mean and How Should It Guide Treatment Decision-Making?","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Potential and challenges of MRD detection with circulating tumor DNA analysis","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"56e901e4-eb09-4372-91d8-288f9a044dbb","ControlNumber":"4637","DisclosureBlock":"","End":"4\/9\/2022 10:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"374","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"151","SessionOnDemand":"False","SessionTitle":"Minimal Residual Disease in Solid Tumors: What Does It Mean and How Should It Guide Treatment Decision-Making?","ShowChatLink":"false","Start":"4\/9\/2022 10:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Klaus Pantel<\/i><\/u><\/presenter>. University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany","CSlideId":"","ControlKey":"0e73f0d1-e353-43e5-ad63-07dc5a077498","ControlNumber":"7283","DisclosureBlock":"","End":"4\/9\/2022 10:50:00 AM","HasWebcast":null,"Highlights":[],"Id":"867","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Klaus Pantel, MD;PhD","PresenterKey":"46add747-f298-460d-bb06-db9c0ee1131f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Biology of micrometastasis and challenges of MRD detection with circulating tumor cells","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"151","SessionOnDemand":"False","SessionTitle":"Minimal Residual Disease in Solid Tumors: What Does It Mean and How Should It Guide Treatment Decision-Making?","ShowChatLink":"false","Start":"4\/9\/2022 10:30:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Biology of micrometastasis and challenges of MRD detection with circulating tumor cells","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"95c4315a-036a-4684-840a-5562f4dfc71a","ControlNumber":"4638","DisclosureBlock":"","End":"4\/9\/2022 11:00:00 AM","HasWebcast":null,"Highlights":[],"Id":"375","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"151","SessionOnDemand":"False","SessionTitle":"Minimal Residual Disease in Solid Tumors: What Does It Mean and How Should It Guide Treatment Decision-Making?","ShowChatLink":"false","Start":"4\/9\/2022 10:50:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Daniel F. Hayes<\/i><\/u><\/presenter>. University of Michigan, Rogel Cancer Center, Ann Arbor, MI","CSlideId":"","ControlKey":"088a69f8-7537-4d04-ae24-d6b6f109d773","ControlNumber":"6772","DisclosureBlock":"<b>&nbsp;D. F. Hayes, <\/b> <br><b>cepheid<\/b> Independent Contractor, consultant\/advisor, No. <br><b>Freenome<\/b> Independent Contractor, consultant\/advisor, No. <br><b>Cellworks<\/b> Independent Contractor, consultant\/advisor, No. <br><b>lexent Bio<\/b> Independent Contractor, consultant\/advisor, No. <br><b>BioVeca<\/b> Independent Contractor, consultant\/advisor, No. <br><b>OncoCyte<\/b> Independent Contractor, consultant\/advisor, No. <br><b>Turnstone biologics<\/b> Independent Contractor, consultant\/advisor, No. <br><b>Predictus Biosciences<\/b> Independent Contractor, consultant\/advisor, No. <br><b>Tempus<\/b> Independent Contractor, consultant\/advisor, No. <br><b>Guardant<\/b> Independent Contractor, consultant\/advisor\u000d\u000a\u000d\u000amay be related - they are working on a liquid biopsy to detect MRD, Yes. <br><b>Macrogenics<\/b> Independent Contractor, consultant\/advisor, No. <br><b>EPIC Sciences<\/b> Independent Contractor, consultant\/advisor. Also, they will sponsor a trial at our institution and others - I am not a PI. Product could be related to MRD, Yes. <br><b>L-Nutra<\/b> Independent Contractor, consultant\/advisor, No. <br><b>Menarini Silicon Biosystems<\/b> Grant\/Contract, Patent, MSB provides research support to UM for my research. UM holds patent that was licensed to MSB and UM and i received annual royalties up to 1\/1\/2021. These related to circulating tumor cells, so could be related to topic., Yes. <br><b>inbiomotion<\/b> Stock Option, consultant\/advisor, No. <br><b>UpToDate<\/b> Independent Contractor, Copyright, i edit the breast cancer section, No.","End":"4\/9\/2022 11:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"434","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Daniel Hayes, MD","PresenterKey":"d690a064-b8e4-4013-b363-9c5187a9f709","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Defining the clinical utility of MRD testing: Path to guiding treatment decision making","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"151","SessionOnDemand":"False","SessionTitle":"Minimal Residual Disease in Solid Tumors: What Does It Mean and How Should It Guide Treatment Decision-Making?","ShowChatLink":"false","Start":"4\/9\/2022 11:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Defining the clinical utility of MRD testing: Path to guiding treatment decision making","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"4eb69ac9-a183-47ff-8bef-c620bad92474","ControlNumber":"4639","DisclosureBlock":"","End":"4\/9\/2022 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"376","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"151","SessionOnDemand":"False","SessionTitle":"Minimal Residual Disease in Solid Tumors: What Does It Mean and How Should It Guide Treatment Decision-Making?","ShowChatLink":"false","Start":"4\/9\/2022 11:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]